milrinone has been researched along with Cardiac Hypertrophy in 4 studies
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The long-term survival of rats with healed myocardial infarction and congestive heart failure treated with milrinone, enalapril and the combination of milrinone plus enalapril, was documented." | 7.67 | Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction. ( Emmert, SE; Heyse, JF; Ludden, CT; Stabilito, II; Sweet, CS, 1988) |
| "The long-term survival of rats with healed myocardial infarction and congestive heart failure treated with milrinone, enalapril and the combination of milrinone plus enalapril, was documented." | 3.67 | Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction. ( Emmert, SE; Heyse, JF; Ludden, CT; Stabilito, II; Sweet, CS, 1988) |
| "We report a 14-month-old child with persistent truncus arteriosus and crossed pulmonary arteries." | 1.43 | Crossed Pulmonary Arteries in a Patient With Persistent Truncus Arteriosus. ( Airan, B; Gulati, GS; Gupta, SK; Rajashekar, P; Talwar, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Talwar, S | 1 |
| Rajashekar, P | 1 |
| Gupta, SK | 1 |
| Gulati, GS | 1 |
| Airan, B | 1 |
| Straznicka, M | 2 |
| Leone, RJ | 1 |
| Scholz, PM | 2 |
| Weiss, HR | 2 |
| Gong, GX | 1 |
| Yan, L | 1 |
| Tse, J | 1 |
| Sweet, CS | 1 |
| Ludden, CT | 1 |
| Stabilito, II | 1 |
| Emmert, SE | 1 |
| Heyse, JF | 1 |
4 other studies available for milrinone and Cardiac Hypertrophy
| Article | Year |
|---|---|
Crossed Pulmonary Arteries in a Patient With Persistent Truncus Arteriosus.
Topics: Abnormalities, Multiple; Anastomosis, Surgical; Cardiomegaly; Cardiopulmonary Bypass; Combined Modal | 2016 |
Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
Topics: Animals; Blood Gas Analysis; Body Weight; Cardiomegaly; Coronary Circulation; Cyclic AMP; Endocardiu | 1998 |
Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiomegaly; Colforsin; Cyclic AMP; Cyclic GMP; Dogs; | 1999 |
Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction.
Topics: Animals; Body Weight; Cardiomegaly; Cardiotonic Agents; Electrocardiography; Enalapril; Heart Failur | 1988 |